Assembly Biosciences, Inc. (HAM:V7B) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of common stock and pre-funded warrants with accompanying Class A and Class B warrants Announced: US$19.6 a share · Warrants at US$21.6 for 60 months · Guggenheim Securities +1 Dealers: Guggenheim Securities (lead), Mizuho (co-lead) Buyers: Commodore Capital; Blackstone Multi-Asset Investing; Farallon Capital Management, L.L.C.; Janus Henderson Investors; RA Capital Management Use of proceeds: General corporate purposes | Aug 8, 2025 |
| Private placement of common stock with accompanying Class A and Class B warrants Announced: private placement Buyers: Gilead Sciences, Inc. (2,295,920 shares of common stock and accompanying Class A and Class B warrants to purchase up to 2,295,920 shares) Use of proceeds: General corporate purposes | Aug 8, 2025 |
| Strategic investment of common stock Closed: US$20.1M raised Buyers: Gilead (approximately $20.1 million equity investment) Use of proceeds: To advance clinical development programs | Mar 20, 2025 |